X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES FULFORD INDIA JUBILANT LIFE SCIENCES/
FULFORD INDIA
 
P/E (TTM) x 16.6 398.8 4.2% View Chart
P/BV x 4.4 6.2 70.4% View Chart
Dividend Yield % 0.4 0.1 490.7%  

Financials

 JUBILANT LIFE SCIENCES   FULFORD INDIA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
FULFORD INDIA
Mar-14
JUBILANT LIFE SCIENCES/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs187942 19.8%   
Low Rs65450 14.5%   
Sales per share (Unadj.) Rs364.3691.4 52.7%  
Earnings per share (Unadj.) Rs6.811.5 59.7%  
Cash flow per share (Unadj.) Rs24.515.4 159.5%  
Dividends per share (Unadj.) Rs3.002.00 150.0%  
Dividend yield (eoy) %2.40.3 828.9%  
Book value per share (Unadj.) Rs164.9380.0 43.4%  
Shares outstanding (eoy) m159.283.90 4,084.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.0 34.3%   
Avg P/E ratio x18.460.7 30.3%  
P/CF ratio (eoy) x5.145.3 11.3%  
Price / Book Value ratio x0.81.8 41.7%  
Dividend payout %43.817.4 251.1%   
Avg Mkt Cap Rs m20,0612,714 739.1%   
No. of employees `0006.20.4 1,393.0%   
Total wages/salary Rs m11,052505 2,188.5%   
Avg. sales/employee Rs Th9,383.06,073.0 154.5%   
Avg. wages/employee Rs Th1,786.91,137.4 157.1%   
Avg. net profit/employee Rs Th176.3100.7 175.1%   
INCOME DATA
Net Sales Rs m58,0342,696 2,152.3%  
Other income Rs m191125 152.0%   
Total revenues Rs m58,2242,822 2,063.4%   
Gross profit Rs m5,786-46 -12,470.3%  
Depreciation Rs m2,81215 18,498.0%   
Interest Rs m3,23710 34,075.8%   
Profit before tax Rs m-7254 -132.8%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m69610 7,254.2%   
Profit after tax Rs m1,09045 2,439.4%  
Gross profit margin %10.0-1.7 -579.4%  
Effective tax rate %-965.917.7 -5,463.3%   
Net profit margin %1.91.7 113.3%  
BALANCE SHEET DATA
Current assets Rs m29,2801,738 1,684.4%   
Current liabilities Rs m38,912545 7,143.7%   
Net working cap to sales %-16.644.3 -37.5%  
Current ratio x0.83.2 23.6%  
Inventory Days Days8448 174.1%  
Debtors Days Days514 1,177.5%  
Net fixed assets Rs m55,71212 468,165.5%   
Share capital Rs m15539 396.2%   
"Free" reserves Rs m20,9681,443 1,453.1%   
Net worth Rs m26,2651,482 1,772.3%   
Long term debt Rs m17,1690-   
Total assets Rs m88,6062,077 4,266.7%  
Interest coverage x1.06.7 14.6%   
Debt to equity ratio x0.70-  
Sales to assets ratio x0.71.3 50.4%   
Return on assets %4.92.6 187.1%  
Return on equity %4.23.0 137.6%  
Return on capital %11.64.3 268.7%  
Exports to sales %37.80-   
Imports to sales %16.524.5 67.4%   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567659 1,451.2%   
Fx inflow Rs m22,00417 127,930.8%   
Fx outflow Rs m11,749673 1,745.3%   
Net fx Rs m10,255-656 -1,563.4%   
CASH FLOW
From Operations Rs m8,02690 8,917.9%  
From Investments Rs m-1,744105 -1,667.5%  
From Financial Activity Rs m-4,447-14 31,541.8%  
Net Cashflow Rs m1,834181 1,016.3%  

Share Holding

Indian Promoters % 45.6 0.0 -  
Foreign collaborators % 3.5 75.0 4.7%  
Indian inst/Mut Fund % 8.7 3.8 228.9%  
FIIs % 21.2 0.1 21,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 21.2 99.5%  
Shareholders   23,815 4,783 497.9%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   ALKEM LABORATORIES  PLETHICO PHARMA  GLENMARK PHARMA  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Realty & Auto Stocks Top Losers(09:30 am)

Asian shares eased in holiday-thinned trading on Monday and the safe haven yen gained as China canceled upcoming tariff talks with the United States.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY18); Net Profit Up 1.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 1.4% YoY). Sales on the other hand came in at Rs 23 bn (up 37.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Sep 24, 2018 12:37 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS